Carfilzomib, lenalidomide, and dexamethasone (KRd) versus elotuzumab and KRd in transplant-eligible patients with newly diagnosed multiple myeloma: Post-induction response and MRD results from an open-label randomized phase 3 study

被引：0

作者：

Knop, Stefan

Stuebig, Thomas

Kull, Miriam

Greil, Richard

Steiner, Normann

Bassermann, Florian

Nogai, Axel

von Lilienfeld-Toal, Marie

Janjetovic, Snjezana

Trautmann-Grill, Karolin

Bittrich, Max

Engelhardt, Monika Martha

Hoferer, Anette

Theurich, Sebastian

Binder, Mascha

Zojer, Niklas

Duerk, Heinz A.

Brueggemann, Monika

Held, Swantje

Einsele, Hermann

机构：

[1] Deutsch Studiengrp Multiples Myelom, Cologne, Germany

[2] Wuerzburg Univ, Med Ctr, Wurzburg, Germany

[3] Schleswig Holstein Univ Hosp, Kiel Campus, Kiel, Germany

[4] Ulm Univ Hosp, Dept Internal Med 3, Ulm, Germany

[5] Hosp Salzburg Paracelus Univ, Salzburg, Austria

[6] Med Univ Innsbruck, Dept Internal Med 5, Innsbruck, Austria

[7] Univ Hosp Rechts Isar, Munich, Germany

[8] Charite Univ Med Berlin, Berlin, Germany

[9] Free Univ Berlin, Berlin, Germany

[10] Humboldt Univ, Berlin, Germany

[11] Med Klin mS Hamatol Onkol & Tumor immunol, Berlin, Germany

[12] Jena Univ Hosp, Dept Hematol & Oncol, Jena, Germany

[13] Helios Klinikum Berlin Buch, Dept Hematol & Oncol, Berlin, Germany

[14] Dresden Univ Hosp Carl Gustav Carus, Dept Hematol & Oncol, Dresden, Germany

[15] Univ Hosp Med Ctr, Freiburg, Germany

[16] Robert Bosch Krankenhaus, Dept Hematol & Oncol, Stuttgart, Germany

[17] Ludwig Maximilians Univ Munchen, Dept Internal Med Hematol Oncol 3, Gene Ctr, Cancer & Immunometabolism Res Grp, Munich, Germany

[18] Martin Luther Univ Halle Wittenberg, Dept Internal Med Oncol Hematol 4, Halle, Germany

[19] Clin Ottakring, Dept Med 1, Ctr Oncol Hematol & Palliat Care, Canc Res Inst, Vienna, Austria

[20] Univ Schleswig Holstein City Hosp Kiel, Med Dept 2, Kiel, Germany

[21] Clinassess Inc, Leverkusen, Germany

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

8000

引用

页数：1